129 related articles for article (PubMed ID: 38904499)
21. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
Pernod G; Joly M; Sonnet B
J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
[TBL] [Abstract][Full Text] [Related]
22. Incorporating assessment of fibrinogen gene polymorphisms and bleeding risk in patients treated with direct oral anticoagulants.
Hwang WYK; Tan CW; Ng HJ
Ann Acad Med Singap; 2023 Jul; 52(7):336-337. PubMed ID: 38904497
[No Abstract] [Full Text] [Related]
23. The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease.
Bahadori B; Uitz E; Dehchamani D; Pilger E; Renner W
Thromb Res; 2010 Oct; 126(4):350-2. PubMed ID: 20709368
[TBL] [Abstract][Full Text] [Related]
24. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.
Becattini C; Giustozzi M; Ranalli MG; Bogliari G; Cianella F; Verso M; Agnelli G; Vedovati MC
J Thromb Haemost; 2018 May; 16(5):833-841. PubMed ID: 29460334
[TBL] [Abstract][Full Text] [Related]
25. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
Kaide CG; Gulseth MP
J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
[TBL] [Abstract][Full Text] [Related]
26. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.
Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F
Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786
[TBL] [Abstract][Full Text] [Related]
27. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
[TBL] [Abstract][Full Text] [Related]
28. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
29. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
30. Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice.
Ogino Y; Ishigami T; Minamimoto Y; Kimura Y; Akiyama E; Okada K; Matsuzawa Y; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Ishikawa T; Tamura K; Kimura K
Circ J; 2020 Jul; 84(8):1330-1338. PubMed ID: 32624519
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
Shaw J; de Wit C; Le Gal G; Carrier M
J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
[TBL] [Abstract][Full Text] [Related]
32. Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk.
Ciou WS; Wang CC; Lin FJ; Chao TF; Lin SY
Heart Rhythm; 2024 Jun; 21(6):715-722. PubMed ID: 38266751
[TBL] [Abstract][Full Text] [Related]
33. Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants.
Adam L; Feller M; Syrogiannouli L; Del-Giovane C; Donzé J; Baumgartner C; Segna D; Floriani C; Roten L; Fischer U; Aeschbacher S; Moschovitis G; Schläpfer J; Shah D; Amman P; Kobza R; Schwenkglenks M; Kühne M; Bonati LH; Beer J; Osswald S; Conen D; Aujesky D; Rodondi N;
J Thromb Haemost; 2021 Apr; 19(4):931-940. PubMed ID: 33501722
[TBL] [Abstract][Full Text] [Related]
34. Bleeding Risk of Add-On Anti-Platelet Agents to Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (From 2216 Patients in the DIRECT Registry).
Sotomi Y; Hirata A; Amiya R; Kobayashi T; Hirayama A; Sakata Y; Higuchi Y
Am J Cardiol; 2019 Apr; 123(8):1293-1300. PubMed ID: 30717887
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.
Nakabori T; Kunimasa K; Kawabata M; Higashi S; Mukai K; Kawamura T; Inoue T; Tamiya M; Nishino K; Ohkawa K
Cancer Med; 2024 Jun; 13(12):e7430. PubMed ID: 38924675
[TBL] [Abstract][Full Text] [Related]
36. Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
Mannila MN; Lovely RS; Kazmierczak SC; Eriksson P; Samnegård A; Farrell DH; Hamsten A; Silveira A
J Thromb Haemost; 2007 Apr; 5(4):766-73. PubMed ID: 17263791
[TBL] [Abstract][Full Text] [Related]
37. Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants.
Yoon HY; Song TJ; Yee J; Park J; Gwak HS
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145636
[No Abstract] [Full Text] [Related]
38. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia.
Rockhold M; Kunkel L; Lacoste JL; Szymanski T; Rothenberg P; Zimmerman P; Minc S
J Vasc Surg; 2024 Jun; 79(6):1466-1472.e1. PubMed ID: 38278371
[TBL] [Abstract][Full Text] [Related]
39. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
40. Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures.
Obi AT; Thompson JR; Beaulieu RJ; Sutzko DC; Osborne N; Albright J; Gallagher KA; Henke PK
J Vasc Surg; 2020 Dec; 72(6):1996-2005.e4. PubMed ID: 32278573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
